Final Thoughts and Conclusions on Multiple Sclerosis

%jwplayer%

The MD Magazine Peer Exchange "Modifying the Course of Multiple Sclerosis in New Ways: The Latest Advances in Treatment" features a distinguished panel of physician experts discussing key topics in multiple sclerosis (MS) research and management, including the latest insights into MS pathophysiology, new medication options and their application in clinical practice, and more.

This Peer Exchange is moderated by Paul Doghramji, MD, who is a family physician at Pottstown Memorial Medical Center in Pottstown, PA, and medical director of Health Services at Ursinus College, in Collegeville, PA.

The panelists are:

• Fred D. Lublin, MD, FAAN, FANA, the Saunders Family Professor of Neurology and director of The Corinne Goldsmith Dickinson Center for Multiple Sclerosis, and co-chief editor of Multiple Sclerosis and Related Disorders at the Icahn School of Medicine at Mount Sinai
• Patricia K. Coyle, MD, professor of neurology, vice chair of Clinical Affairs, and director of MS Comprehensive Care Center
• Suhayl Dhib-Jalbut, MD, professor and chief of the Department of Neurology at Rutgers, Robert Wood Johnson Medical School

When prompted for their closing thoughts, Coyle mentioned the “window of opportunity concept” of early treatment first, along with the importance of “a wellness, health maintenance, vascular risk factor program to really improve CNS function.” Dhib-Jalbut chose to “emphasize the role of the MRI now in managing the disease,” specifically at least the 1.5 Tesla MRI from a good facility. Lublin said, “there’s always something we can do, from the very early patient we’re starting on disease-modifying therapy to the patient with severe disease where we can manage their various symptoms to make their lives better.”